Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
Yusuf A Rajabally,1,2 Shahram Attarian,3,4 Emilien Delmont3,4 1Inflammatory Neuropathy Clinic, University Hospitals Birmingham, Birmingham, UK; 2Aston Medical School, Aston University, Birmingham, UK; 3Reference Centre for Neuromuscular Diseases and ALS, Centre Hospitalier Universitaire La Timone, M...
Guardado en:
Autores principales: | Rajabally YA, Attarian S, Delmont E |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/161c9bf6d2914d018c7772711b9f69e7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Length-dependent changes of lower limb muscle morphology in Chronic Inflammatory Demyelinating Polyneuropathy assessed with magnetic resonance imaging
por: Jacob Fanous, et al.
Publicado: (2021) -
Is Fecal Calprotectin an Applicable Biomarker of Gut Immune System Activation in Chronic Inflammatory Demyelinating Polyneuropathy? – A Pilot Study
por: Magdalena Koszewicz, et al.
Publicado: (2021) -
Acute Neuromuscular Respiratory Weakness Due to Acute Inflammatory Demyelinating Polyneuropathy (AIDP): A Simulation Scenario for Neurology Providers
por: Roshni Abee Patel, et al.
Publicado: (2019) -
Celecoxib Exerts a Therapeutic Effect Against Demyelination by Improving the Immune and Inflammatory Microenvironments
por: Cao P, et al.
Publicado: (2020) -
Factores asociados a respuesta favorable de tratamiento corticoidal en pacientes con polirradiculoneuropatía desmielinizante inflamatoria crónica
por: Fuentealba S.,Mario, et al.
Publicado: (2020)